Review Open Access
Copyright ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Sep 24, 2020; 11(9): 705-722
Published online Sep 24, 2020. doi: 10.5306/wjco.v11.i9.705
Healthcare delivery interventions to reduce cancer disparities worldwide
James C Dickerson, Meera V Ragavan, Department of Internal Medicine, Stanford University, Stanford, CA 94305, United States
Divya A Parikh, Manali I Patel, Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, United States
Manali I Patel, Center for Health Policy/Primary Care Outcomes Research, Stanford University, Stanford, CA 94305, United States
Manali I Patel, VA Palo Alto Health Care System, Palo Alto, CA 94306, United States
ORCID number: James C Dickerson (0000-0002-8935-2939); Meera V Ragavan (0000-0002-8991-0259); Divya A Parikh (0000-0002-7432-4601); Manali I Patel (0000-0002-9943-5762).
Author contributions: All authors contributed to the design and writing of the paper. Patel MI provided additional oversight.
Conflict-of-interest statement: The authors have nothing to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: James C Dickerson, MD, Doctor, Department of Internal Medicine, Stanford University, Lane Building L154, 300 Pasteur Dr, Stanford, CA 94305, United States. jcdicker@stanford.edu
Received: April 12, 2020
Peer-review started: April 12, 2020
First decision: April 22, 2020
Revised: July 7, 2020
Accepted: September 1, 2020
Article in press: September 1, 2020
Published online: September 24, 2020

Abstract

Globally, cancer care delivery is marked by inequalities, where some economic, demographic, and sociocultural groups have worse outcomes than others. In this review, we sought to identify patient-facing interventions designed to reduce disparities in cancer care in both high- and low-income countries. We found two broad categories of interventions that have been studied in the current literature: Patient navigation and telehealth. Navigation has the strongest evidence base for reducing disparities, primarily in cancer screening. Improved outcomes with navigation interventions have been seen in both high- and low-income countries. Telehealth interventions remain an active area of exploration, primarily in high income countries, with the best evidence being for the remote delivery of palliative care. Ongoing research is needed to identify the most efficacious, cost-effective, and scalable interventions to reduce barriers to the receipt of cancer care globally.

Key Words: Intervention, Cancer, Disparity, Health services research, Global oncology, Navigation, Telehealth

Core Tip: Equitable delivery of cancer care requires the study of interventions that can improve access for historically disadvantaged groups. In this review we examine two approaches, patient navigation and telehealth, that have been implemented globally to reduce cancer disparities. Navigation has the most robust evidence, largely for improving cancer screening, and telehealth remains an area of exploration, primarily for the remote delivery of palliative care.



INTRODUCTION

Despite significant advances in cancer prevention and treatment over the last few decades, disparities in cancer outcomes persist across many nations[1,2]. Specifically, cancer incidence and mortality are higher among particular racial and ethnic groups, populations from less developed nations, populations with low incomes, and those who live in rural areas[3-6]. These demographic and sociocultural disparities exist in all phases of cancer care, including prevention, treatment, palliation and survivorship. For example, cervical cancer screening rates are lower among people in many African countries as compared to people living in more affluent western European countries; colon cancer mortality is greater among Hispanic Americans as compared with non-Hispanic whites; and, Black Americans experience higher rates of undertreated pain at the end of life than white Americans[7-9]. The roots of these disparities are multifactorial with historical and social context, financial toxicity, access to care, support systems, and health literacy all playing a significant role[10-13]. Addressing these disparities in cancer care is a stated goal of many national health agencies and international organizations, such as the National Cancer Institute, the World Health Organization, and the World Bank[14-16].

While many studies have focused on characterizing disparity, fewer have described interventions to reduce them. Within this relatively small body of literature there is great diversity: Information campaigns, outreach programs, patient navigation, phone-based applications, and online stress management tools have been trialed. While some interventions have been shown to reduce gaps in cancer care, the reproducibility, scalability, and generalizability is often not known.

In this narrative review we seek to highlight two broad categories of patient-facing health services interventions that aim to reduce disparities in cancer care globally: Patient navigation (with a focus on community health workers) and telehealth. We additionally comment on the generalizability and scalability of these published approaches. Articles were identified either through hand search or via search on CINAHL, EMBASE, MEDLINE, or PubMed using search strings including terms such as “disparity”, “cancer”, “technology”, and “navigation”. We emphasize randomized trials from high income nations, primarily available from the United States, and review data from studies performed in low and middle income countries (LMICs)[17]. Lastly, we sub-divide each section by the phase of care, specifically into (1) prevention, screening and early detection; (2) treatment with cancer therapeutics; and (3) palliation and survivorship.

PATIENT NAVIGATION and COMMUNITY HEALTH WORKERS

In this review, we define “patient navigation” as the process of a patient advocate serving as a guide for patients throughout the cancer care continuum. Patient navigation is one of the most widely studied health services interventions in oncology[18,19]. Navigation services are often delivered by non-professionally trained persons i.e., lay or community health workers (CHWs), primarily as they are more cost-effective (in comparison to training a nurse to deliver the care) and can be selected from the community for which the intervention is designed to impact (for example a “Promotora” for Hispanic American communities). Patient navigation programs vary in their approaches of the navigator role, with some programs providing extensive guidance through the healthcare system while others are limited to one or two aspects of care. The most basic form includes the dissemination of information within a community by a CHW, while the most extensive navigator programs provide assistance with appointments, insurance, and transportation among other activities. Although CHWs have been used in primary and preventative care for over a half-century, CHW delivered navigation services for cancer care have only been seen on a broad scale in the last thirty years[20-22].

Prevention, screening and early detection

The role of patient navigation in oncology was first described in the 1990s in a single-institution, landmark study in New York City[22]. A hospital in Harlem found that the five-year breast cancer survival rates among their predominantly Black patient population was 39%, considerably lower than the national five-year survival rate of 65% among white women. This difference was felt to be driven by later stage diagnoses in Black women[23]. To address this, the Harlem Hospital developed the “Cancer Control Center of Harlem,” a program comprised of numerous free clinics to provide breast cancer screening in conjunction with a patient navigator program. Navigators assisted eligible uninsured patients in applying for health insurance, made follow-up appointments for abnormal mammograms and breast biopsies, helped transcend financial barriers to access ambulatory clinics, and served as communicators of information regarding screening and diagnosis in a culturally sensitive manor. Implementation of this CHW patient navigator program resulted in increased rates of earlier stage cancer diagnoses among Black women from 6% to 41% and decreased late stage breast cancer diagnoses from 49% to 21% between 1964-1986 and 1995-2005[24].

The Harlem Hospital program was the first to describe the impact of a patient navigator study in improving rates of cancer screening in the United States, leading to the adoption of patient navigator programs across other institutions and integration into government policy[25]. In the mid-2000s, increased funding for navigation interventions from the National Cancer Institute through the Patient Navigation Research Program led to a number of randomized controlled trials (RCTs) in the United States (Table 1)[26]. Many of these RCTs examined the effect of navigation on cancer screening, and most reported improvements in the screening rate. As an example, in Percac-Lima et al[27] patients (n = 1223) overdue for colorectal cancer (CRC) screening at a single urban community health center in Chelsea, MA were randomized to either a navigation intervention or usual care. Navigation was led by a community health worker who sent patients an introductory letter and then contacted the patient by phone or in person multiple times. Navigators provided education on the importance of screening, as well as assistance with scheduling, transportation, and applying for insurance. The primary endpoint, the percentage of patients that received CRC screening at nine months, was met. Specifically, 27% of those in the navigation group received screening in comparison to the 12% in the control group (P < 0.001)[27]. Improved CRC screening rates with navigation have also been demonstrated in other patient populations (Table 1).

Table 1 Randomized trials from the United States focusing on navigation interventions to improve outcomes in cancer care for historically marginalized populations.
Ref.PopulationCancer typeNavigator typeTime pointOutcomeResult (intervention vs control)Location
ScreeningJandorf et al[91] (2005)aHispanic (82% of n = 78)CRCLay navigator vs usual care6 moScreening rateEndoscopy: 16% vs 5% (P = 0.019) | FOBT: 42% vs 25% (P = 0.086)New York, NY (urban)
Tu et al[92] (2006)aChinese Americans (n = 210)CRCEducation + FOBT card vs usual care6 moFOBT rate70% vs 28% (P < 0.05)Seattle, WA (urban)
Christie et al[93] (2008)aHispanic (71% of n = 25)CRCLay navigator vs usual care3 moColonoscopy rate54% vs 13% (P = 0.058)New York, NY (urban)
Percac-Lima et al[27] (2009)aLow income (n = 1223)CRCLay navigator vs usual care9 moScreening rate27% vs 12% (P < 0.001)Boston, MA (urban)
Ma et al[94] (2009)bKorean Americans (n = 167)CRCLay navigator vs usual care12 moScreening rate77% vs 11% (P < 0.001)NR
Phillips et al[95] (2011)bAfrican American (47% of n = 3895)BreastLay navigator vs usual care9 moMammography rate87% vs 76% (P < 0.001)Boston, MA (urban)
Lasser et al[96] (2011)aLow income (n = 465)CRCLay navigator vs usual care12 moScreening rate34% vs 20% (P < 0.001)Boston, MA (urban)
Myers et al[97] (2014)aAfrican American (n = 764)CRCMailed FOBT and reminder +/- lay navigation12 moScreening rate44% vs 32% (P = 0.001)Philadelphia, PA (urban)
Braschi et al[98] (2014)aHispanic (n = 392)CRCCulturally tailored lay navigation vs standard navigationNRColonoscopy rate82% vs 79% (P > 0.05)New York, NY (urban)
Enard et al[99] (2015)aHispanic (n = 303)CRCLay navigator vs mailed information16 mo (average, not pre-specified)Screening rate44% vs 32% (P = 0.04)Houston, TX (urban)
Braun et al[100] (2015)aHawaiian and Filipino (90% of n = 488)MultiplecLay navigator vs usual careNRScreening ratePap: 57% vs 36% (P = 0.001) | Mammogram: 62% vs 42% (P = 0.003) | Prostate: (54% vs 36% (P = 0.008) | CRC: 43% vs 27% (P < 0.001)Hawai‘i (rural and urban)
Marshall et al[28] (2016)aAfrican American (n = 1905)BreastLay navigator vs pamphlet18 mo (average, not pre-specified)Screening rate93% vs 88% (P < 0.001)Baltimore, MD (urban)
Percac-Lima et al[101] (2016)aNon-adherent patients (n = 1612)MultiplecLay navigator vs usual care8 moPercentage of patients up to date on all screens10% vs 7% (P < 0.001)Boston, MA (urban)
Degroff et al[102] (2017)aLow income (n = 843)CRCLay navigator vs usual care6 moScreening rate61% vs 53% (P = 0.021)Boston, MA (urban)
Thompson et al[103] (2017)aHispanic (n = 443)CervicalVideo + lay navigation vs usual care7 moScreening rate53% vs 34% (P < 0.001)Washington and Oregon (rural)
Ma et al[104] (2019)bKorean Americans (n = 925)CRCLay navigator + group teaching + FIT card vs usual care12 moScreening rate69% vs 16% (P < 0.001)NR
Diagnostic resolutionEll et al[105] (2007)aHispanic (n = 204)BreastSocial worker navigation vs usual care2 moCompletion of follow-up testing90% vs 66% (P < 0.001)Los Angeles, CA (urban)
Ferrante et al[106] (2008)aAfrican American and Hispanic (87% of n = 105)BreastLay navigator vs usual careN/AMean time to diagnosis (days)25 vs 43 (P = 0.001)Newark, NJ (urban)
Raich et al[107] (2012)a72% non-white (n = 993)MultipledLay navigator vs usual care12 moCompletion of follow-up testing88% vs 70% (P < 0.001)Denver, CA (urban)
Lee et al[108] (2013)bHispanic (60% of n = 1039)BreastLay navigator vs usual careN/ATime to diagnosis2.0 mo vs 1.7 mo (P > 0.05)Tampa, FL (urban)
TreatmentEll et al[40] (2009)aLow income (n = 487)Breast and GynecologicalLay navigator + social worker vs usual care12 moChemotherapy completed as scheduledBreast: 62% vs 75% (P = 0.47) | Gyn: 63% vs 46% (P = 0.13)Los Angeles, CA (urban)
PalliationFischer et al[49] (2018)aHispanic (n = 223)AllLay navigator doing at least 5 home visits + educational packet vs usual careEnrollment till end of lifeAdvance care planning, pain scores, hospice useDocumentation: 65% vs 36% (P < 0.001) | Pain reduction ND (P = 0.88) | Hospice use ND (P = 0.58)Colorado (urban and rural)
Patel et al[50] (2018)aRural veterans (n = 213)AllLay navigator discussing advanced care planning vs usual care6 moAdvanced care planning documentationDocumentation: 92% vs 18% (P < 0.001)Palo Alto, CA (urban and rural)

Marshall et al[28] examined the effect of navigation on mammography rates. Black women with Medicare insurance in Baltimore, MD (n = 1905) were recruited from both the community and a primary care clinic affiliated with an academic medical center. The intervention group received navigation in the form of education, “coaching”, and assistance with arranging appointments. The control arm received a pamphlet on mammography. With a median follow-up of eighteen months, the primary outcome, patient reported mammography in the last two years, was met with 93% reporting mammography in the intervention group vs 88% in the control group (P < 0.001). While the overall effect size appears modest, when patients out of compliance with screening recommendations at study entry were examined alone, the effect was more robust: 73% were up to date in the intervention arm vs 46% in the control at study exit (P < 0.001)[28].

Some trials examined the effect of navigation on time to follow-up for an abnormal cancer screening test. In the United States, three of four RCTs (Table 1) showed improvements in follow-up. In a retrospective analysis of all the patients (n = 10521) in nine studies funded by the Patient Navigation Research Program in the United States, there was large variability in the results— some sites reported up to 20% improvement in follow-up of abnormal screens while other institutions saw no meaningful difference with navigation. The largest improvements were seen in centers with low baseline follow-up, echoing the suggestion that focusing resources on the most at risk populations may yield the greatest improvements[29].

Table 2 shows patient navigation and CHW interventions in LMICs. Notably, this excludes a large body of non-peer reviewed reports from governments, the World Health Organization, and the World Bank. Interventions in LMICs often highlight limitations in resources[30,31]. For example, the largest breast cancer screening studies from LMICs use the clinical breast exam rather than mammography as this was seen as a more scalable and cost-effective option in these nations[32-35]. In three large studies, two from India and one from the Philippines, trained CHWs conducted clinical breast exams—each study screened 100000–150000 women—and provided guidance on the next steps after a positive screen. However, a large percentage of patients with a positive screen were lost to follow-up and thus never received a mammogram, biopsy, or visit with a professionally trained health care worker. While in Sankaranarayanan et al[32] (2011) the follow-up rate was not reported, in Mittra et al[33] the follow-up rate in Mumbai for abnormal exams was only 68%-78%. In Pisani et al[34] the follow-up was so poor in the Philippines at 35% that the study was closed early.

Table 2 Patient-facing studies from low- and middle-income countries involving either a navigation or technology-based component of the intervention.
Ref.Study designCountryCancer typeIntervention typeTime pointOutcomeResult (intervention vs control)Location
ScreeningThomas et al[35] (2002)Cluster randomized trialChina (n = 266064)BreastClasses teaching self-breast exam with supervised exams every 6 mo vs none10 yrDeaths attributable to breast cancer0.1% vs 0.1% (P = 0.67)Factory workers in Shanghai (urban)
Mittra et al[34] (2010)Cluster randomized trialIndia (n = 151538)BreastLay health care workers doing clinical breast examination vs social worker delivered education3 rounds of screening at 2-yr intervalsDownstaging at diagnosis1st round: ND (P = 1.00) | 2nd round: ND (P = 0.47) | 3rd round lower stage at diagnosis (P = 0.004)Slums in Mumbai (urban)
Sankaranarayanan et al[32] (2011)Cluster randomized trialIndia (n = 115652)BreastLay worker clinical breast exam vs education only3 yrStage at diagnosisEarly-stage diagnosis: 44% vs 25% (P = 0.023) | Advanced-stage diagnoses: 45% vs 68 (P = 0.005)Thiruvananthapuram, Kerala (suburban)
Ma et al[109] (2012)Cluster randomized trialChina (n = 453)BreastEducation + lay navigation vs printed materials6 moScreening rate73% vs 5% (P < 0.001)Employees in Nanjing (urban)
Shastri et al[110] (2014)Cluster Randomized TrialIndia (n = 151538)CervicalLay health care workers doing cervical examination vs social worker delivered education12 yrCervical cancer mortality (rate per 100000 person years of observation)11% vs 16% (P = 0.003)Slums in Mumbai (urban)
Abiodun et al[111] (2014)Cohort trial with control from neighboring area (quasi-experimental design)Nigeria (n = 700)CervicalPatient education by medical students vs none3.25 moCervical cancer screening rate8% vs 4% (P = 0.038)Ogun state (rural)
Rosser et al[112] (2015)Randomized controlled trialKenya (n = 251)CervicalLay health worker 30-minute educational talk vs none3 moScreening rate59% vs 61% (P = 0.60)Homa Bay County (rural)
Lima et al[113] (2017)Randomized cohort trialBrasil (n = 524)CervicalBehavioral telephone interview vs educational telephone callNRScreening rate67% vs 58% (NR)Women without up-to-date screens in Fortaleza (urban)
Diagnostic resolutionPisani et al[33] (2006)Single arm description of a cluster randomized trialPhilippines (n = 151168)BreastLay health worker clinical breast exam2 yrFollow-up for abnormal screening exam35% follow-up rateManila (urban)
Ginsburg et al[36] (2014)Cluster randomized trialBangladesh (n = 22337)BreastCHW with smartphone +/- additional CHW training to navigateNRFollow up care if abnormal CBE63% vs 43% (no navigation) (P < 0.0001)Khulna Division (rural)
Mishra et al[114] (2017)Retrospective descriptive studyIndia (n = 2610432)Head and NeckCHWs doing physical exams, counseling patients to stop smoking, and referring patients to an ENT practice if a positive exam3 yrReferral to tertiary care center2610432 screened | 10522 (1.1%) quit smoking | 3309 (0.13%) referred to tertiary care center of which 1890 (57%) were positive for cancer | 1712 (91%) diagnosed were able to start treatmentGujarat (rural)
Riogi et al[38] (2017)Cohort study with retrospective control groupKenya (n = 75)BreastCohort of patients cared for by nurses trained to navigate vs historic cohort1 moCompletion of follow-up testing58% vs 24% (P = 0.0026)Nairobi (urban)
Vasconcelos et al[39] (2017)Randomized cohort trialBrasil (n = 775)CervicalTying ribbon with appointment date on hand vs education session vs card reminder2 moReturn for pap test results66% vs 82% (education) vs 77% (control) (P < 0.05)Fortaleza (urban)
Chavarri-Guerra et al[115] (2019)Retrospective descriptive studyMexico (n = 70)AllLay navigator3 moObtain appointment at cancer center91% had appointment at 3-mo censorMexico City (urban)
Mireles-Aguilar et al[116] (2018)Retrospective descriptive studyMexico (n = 656)BreastMedia campaigns for navigation program followed by navigation by a nurse if alert activatedNRFollow-up for self-reported symptomatic breast lesions69% attendance to appointment | Median time from alert activation to treatment (n = 22): 33 daysNuevo Leon state (urban and rural)
TreatmentLi et al[117] (2016)Randomized controlled trialChina (n = 66)Bladder"Enhanced" nursing care including phone follow-ups vs usual nursing careNRFollow-up after tumor resection86% vs 63% (P = 0.032)Laiwu, Shandong province (NR)
Alvarez et al[45] (2017)Retrospective descriptive studyGuatemalan children (n = 1,789)AllMultifaceted intervention including transportation, food, shelter, and education/guidance on the importance of completing treatmentN/ATreatment abandonment (year 2001 vs 2008)27% vs 7% (NR)Guatemala City (urban and rural)
Yeoh et al[46] (2018)Cohort study with retrospective control groupMalaysia (n = 283)BreastNurses who received additional education in patient navigation vs retrospective cohortN/ATreatment abandonment4% vs 12% (P = 0.048)Klang (suburban)
PalliativeSajjad et al[118] (2016)Parallel cohort trailPakistan (n = 50)BreastNurse delivered education series + nurse delivered support during chemotherapy sessions + nurse phone follow-ups vs none1.5 moChange in global quality of life scoreImprovement for the intervention group (P = 0.020) | No change for historic cohort (P = 0.111)Karachi (urban)
Nejad et al[119] (2016)Parallel cohort trailIranian caregivers of cancer patients (n = 60)BreastNurse delivering 2 in-person education / training sessions + 4 telephone follow-up sessions vs noneNRChange in caregiver strain index scoresImproved scores for the intervention group (P = 0.001)Tabriz (urban)

In an effort to improve these poor historical follow-up rates, investigators have examined adding navigation training for CHWs. In Bangladesh (n = 22337), two groups of CHWs were trained to perform clinical breast exams. One group received an additional day of training on how to identify barriers to follow-up, troubleshoot these obstacles, and accompanied patients to follow-up appointments. The follow-up rate (being seen by a trained medical professional) for abnormal clinical exams by the CHWs improved from 43% to 63% (P < 0.01)[36]. Similar interventions have been documented in other LMICs. In Nairobi, Kenya, a clinic offering free clinical breast exams trained nurse navigators using a curriculum developed at the University of Colorado (one of the sites in the Patient Navigation Research Program in the United States). Nurses called and texted patients to remind them of their appointments and provided additional support[37]. This intervention resulted in surgical consultation for abnormal breast exams among 58% of women enrolled in the study as compared to the baseline historic rate of 24% (P < 0.01)[38].

While many studies report positive results in cancer screening and follow-up of abnormal screening exams with patient navigation, there are some studies that have not found improvements with navigation. In a study of Brazilian women undergoing cervical cancer screening through Papanicolaou testing at a single urban center (n = 775), patients were randomized to either receive a written card with a follow-up date on it (control), education on the importance of returning to the clinic and follow-up for the results (education), or a novel patient navigation method where different colored wristbands with reminders were tied onto the wrists of patients (navigation group). The navigation group had a lower follow-up rate (66%) than both the education group (82%) and the control (77%) (P < 0.05)[39]. This highlights the importance of studying the interventions prior to implementation as not all interventions are acceptable, feasible, or produce the same results given differences in the clinical and cultural context of the healthcare system and the community. There are many features of navigation programs, such as the additional social support, problem solving, human contact, and reminders that are likely to be beneficial in all settings, however they may require local adaptation with exploration of novel techniques and environments to ensure their success.

Treatment

Navigation studies among patients undergoing treatment for cancer are limited. In Ell et al[40], low-income patients (n = 487) diagnosed with breast or cervical cancer at an academic hospital in Los Angeles were randomized to either receive usual care (financial counseling, pamphlets, and as needed social work) vs lay navigation with automatic social work referral. There was no significant difference in the primary outcome, treatment adherence at twelve months, between the two arms[40].

In multiple studies comparing pre- vs post-implementation of a navigator program in the United States, there have been positive effects reported for on-treatment cancer patients. In a unique study designed to increase Black patient participation in lung cancer clinical trials, the University of Alabama trained two Black health workers to serve as patient navigators. The navigators reviewed the purpose of clinical trials with patients, completed a needs assessment to identify barriers to participation in clinical trials, helped refer patients to social workers or other community resources when needed (such as transportation and lodging), accompanied patients to their clinical visit, and called patients to remind them of appointments. Patients who opted for navigation services had a trial completion rate of 75% in comparison to 38% for non-navigated patients[41]. In an effort to decrease Black-white disparities in early stage lung cancer, a study at two cancer centers in Pittsburgh and North Carolina used a navigator to proactively reach out to Black patients who missed appointments to identify and resolve barriers to care. The Black-white gap in receipt of curative intent surgery or radiation was eliminated, and treatment rates for Black patient (n = 144) rose from 69% to 97%[42]. In Texas, a similar proactive lay navigator model for Hispanic patients (n = 200) with breast cancer correlated with earlier treatment initiation of 1.9 mo vs 2.4 mo for a historical group (P = 0.04)[43]. In South Dakota, a cohort of lay navigated American Indians (n = 332) receiving curative intent radiation (all cancer types) were found to have less treatment interruptions (average 2 d of interruption) in comparison to a historical cohort (average 5 d)[44].

These non-randomized studies collectively suggest that navigation interventions improved follow-up rates and adherence to treatment and correlated with consistent improvements in cancer outcomes for marginalized groups. In LMICs, similarly, multiple non-randomized studies suggest that navigation and CHW interventions can reduce gaps in adherence to treatment follow-up. At a pediatric cancer center in Guatemala City, a comprehensive multidisciplinary intervention was implemented which provided food, transportation, education, and counseling services to both patients and their families. Treatment abandonment fell from 27% to 7% after implementation of the program. Factors associated with higher abandonment rates included distance from the cancer center, age, and indigenous race[45]. In Malaysia, an urban state hospital examined the outcomes of navigated breast cancer patients (n = 135) in comparison to a historical cohort during early treatment. The intervention resulted in reduced treatment abandonment from 12% to 4% (P = 0.048)[46]. These results from both the United States and LMICs suggest again that interventions targeting the most at risk groups may yield the largest effect size.

Palliation and Survivorship

Navigation interventions to reduce disparities in palliative care and survivorship have not been extensively studied, despite evidence that such disparities exist in the receipt of palliative care[47,48]. One program, Apoyo con Cariño (Support with Caring) based in clinics across rural and urban Colorado implemented a lay navigator program with the aim of improving palliation in Hispanic patients (n = 223) with advanced cancer. In this program, the navigator made home visits to discuss both advanced care planning and pain/symptom management with the patient. They also helped coordinate contact with the primary oncologist to discuss action plans for uncontrolled symptoms. The study resulted in an increase in the rate of documentation of goals of care, but did not lead to any significant differences in patient reported pain reduction or utilization of hospice services[49]. An RCT based at a Veterans Affairs (VA) hospital in California tested the efficacy of a lay health worker-led advance care planning intervention in patients with any type of advanced cancer (n = 213). At six months, the study demonstrated greater goals of care documentation and hospice use, and lower acute care use among patients in the intervention as compared to the control. It was also found that this intervention decreased healthcare expenditure for the VA system, suggesting that this may be a cost-effective model from the perspective of the payor[50]. Further studies of lay health care worker interventions in low income populations in the United States are ongoing[51,52].

Summary and future directions

In summary, navigation employed across the cancer care continuum has successfully improved cancer screening rates, follow-up, adherence to treatment, and goals of care documentation. Although the most robust data is from the United States, and is specifically for colorectal and breast cancer screening, a positive impact on cancer care delivery has been seen in both high income countries and LMICs. Gaps in the literature remain regarding the cost-effectiveness of patient navigator interventions which is crucial in informing communities, health systems, and policy in the adoption of navigator programs globally.

MOBILE HEALTH AND TELE-ONCOLOGY

For the purposes of this review, we define telehealth as any form of telecommunication (video, voice only, apps, etc.) to support patient’s remote access to health care services. These interventions span text message reminders, phone applications for palliation, and decision aides[53-55]. Although not as well studied as patient navigation interventions, telehealth interventions have increasingly been investigated to improve cancer care delivery. Access to mobile phones is becoming common in LMICs, including in rural communities, making telehealth a potentially powerful tool to reduce disparities in healthcare delivery[56-59].

Screening

Several randomized telehealth-based intervention trials have evaluated cancer screening in underserved populations (Table 3). Where navigation trials often focus on care coordination, telehealth interventions largely consist of education (often delivered via multimedia) and assisting patients in decision making[55,60,61]. Published studies of telehealth interventions in cancer are also limited to shorter follow-up periods (often 6 mo or less, range 1-15 mo) in comparison to patient navigation studies where 16 of 17 studies (Table 1) had follow-up periods of at least 6 mo (range 3-18 mo).

Table 3 Randomized trails from the United States examining technology interventions to improve outcomes in cancer care for historically marginalized populations.
Ref.PopulationCancer typeTechnologyTime pointOutcomeResult (intervention vs control)Location
ScreeningMiller et al[120] (2005)aAfrican American (70% of n = 194)CRCEducational multimedia computer program vs nurse instruction on using FOBT card1 moCompleted FOBT kit62% vs 63% (P = 0.89)Winston Salem, NC (urban)
Dignan et al[121] (2005)aNative American (n = 157)BreastLay navigator on phone vs lay navigator in person12 moScreening rate42% vs 45% (P = 0.83)Denver, CA (urban)
Champion et al[62] (2006)aAfrican Americans (n = 344)BreastInteractive educational computer program vs video vs pamphlet6 moMammography rate40% vs 25% (video) vs 32% (pamphlet) (P = 0.037)Indianapolis, IN (urban)
Russell et al[63] (2010)aAfrican American (n = 181)BreastInteractive educational computer program + monthly lay navigation vs pamphlet6 moMammography rate51% vs 18% (P < 0.001)Indianapolis, IN (urban)
Miller et al[122] (2011)aAfrican American (75% of n = 264)CRCWeb-based decision aid vs usual care6 moCompletion of CRC screening19% vs 14% (P = 0.25)Winston Salem, NC (urban)
Greiner et al[64] (2014)aLow income (n = 470)CRCComputer-delivered information on screening +/- implementation intentions theory-based behavior modification tool6.5 moCompletion of CRC screening54% vs 42%, (P < 0.01)Kansas City, KS (urban)
Fernandez et al[123] (2015)bHispanic (n = 665)CRCInteractive educational multimedia on a tablet vs video vs none6 moCompletion of CRC screening10% vs 14% (video) vs 11% (none) (P = 0.46)Lower Rio Grande Valley in Texas (rural)
Valdez et al[124] (2019)aHispanic (n = 943)CervicalKiosk delivered education versus pamphlet6 moPap rate51% vs. 48% (P = 0.35)Los Angeles, San Jose, and Fresno, CA (urban)
TreatmentHelzlsouer et al[65] (2018)aAfrican American (n = 101)BreastWeb-based navigation program versus list of websites12 moAdjuvant treatment completion94% vs 86% (P = 0.24)Baltimore, MD (urban)
Percac-Lima et al[66] (2015)aLikely to no show (n = 4425)AllLay navigator vs usual care5 moNo show rate10% vs 18% (P < 0.001)Boston, MA (urban)
PalliationBakitas et al[77] (2009)aRural patients (n = 322)AllPsycho-educational classes followed by monthly tele-health check-ins with advanced nurse practitioner vs usual careDeath or study completion (5 yr)Quality of lifeIntervention > control for quality of life (P = 0.02) and mood scores (P = 0.03) | ND in symptom intensity (P = 0.24)Vermont (rural)
Kroenke et al [75] (2010)aLow income (n = 405)AllTelecare management with automated home-based symptom monitoring by interactive voice recording or internet vs usual care12 moImprovement in pain and depression scalesIntervention > control for pain and depression (P < 0.0001 for both)Indiana (rural and urban)
Yanez et al[76] (2015)aAfrican American (40% of n = 74)ProstateCognitive-behavioral stress management delivered via web/tablet vs generic health information via web/tablet6 moDepression scale changeND (P = 0.06)Chicago, IL (urban)
Anderson et al[125] (2015)aAfrican American and Hispanic (n = 60)BreastTwice weekly automated telephone calls with patient rating of pain. If pain was elevated, e-mail sent to clinician vs usual care2-2.5 moReduction in pain severity from baselineIntervention > control (P = 0.015)Houston, TX (urban)
Ramirez et al[78] (2020)aHispanic (n = 288)Breast, CRC, and ProstateIntensified telephone and internet-based patient navigation vs “standard” navigation15 moChange in health-related quality of life scoreIntervention > control (P < 0.05) for female CRC patients | Intervention = control (P > 0.05) for breast cancer, male CRC, and prostateChicago, IL and San Antonio, TX (urban)

Among the eight screening RCTs included in Table 3, three reported positive outcomes. Two of these studies were based in urban Indiana and evaluated the impact of an interactive informational computer-based education program on mammography rates for Black women (n = 344 and 181) at six months. In both studies, the intervention group received a computer-based education program that included questions as a mechanism to give a tailored message in response to the participant's knowledge and health beliefs about breast cancer and mammography screening. This was compared to a control group who received pamphlets and a DVD. The first study, with this intervention alone, showed a robust increase in screening rate at study exit (40% vs 27%, P = 0.024). The second study added a lay navigator to the same educational program and demonstrated a larger effect size on mammography rate (51% vs 18%, P < 0.01). These studies suggest that the combination of self-learning, electronic modules to patient navigation may be more effective than technology alone[62,63]. The third positive trial was conducted in nine urban safety-net clinics in Kansas City, MO. The study randomized patients eligible for CRC screening (n = 470) to a generic education intervention (control) or the same education intervention plus a series of “implementation intentions” questions. Both arms used a touchscreen computer at the clinic site to deliver the education, and the intervention arm received a series of questions after the education focused on how the patient could keep track of appointments, prepare for a colonoscopy, and arrange for childcare/transport that day if applicable, etc. Those in the experimental group achieved a higher rates of screening at 6.5 mo of follow-up in comparison to the control group (54% vs 42%, P < 0.001)[64]. These positive trials generally used interventions that focused on both education and behavior. In comparison, the negative trials frequently used tablets or websites to deliver educational media alone. While these negative studies often did demonstrate improvement in knowledge base (often immediately after the intervention), it did not appear to translate to an increase in screening rates with limited follow-up periods (Table 3).

Treatment

We are aware of only two RCTs investigating the impact of technology on treatment adherence. One trial of predominately Black women (n = 101) at a single site in Baltimore, MD aimed to improve treatment adherence to adjuvant therapy for breast cancer with the use of a web-based information tool in addition to phone check-ins by a patient navigator every two weeks. The primary endpoint, adherence at twelve months, was not significantly different between the two groups[65]. The second study, Percac-Lima et al[66], used a novel method to identify at risk individuals. All cancer patients at a single academic medical center in Boston predicted to be at risk of being lost to follow-up (n = 4425) were randomized to phone navigation vs usual care. The intent to treat analysis demonstrated lower no-show rates with navigation (10% vs 18%, P < 0.01). The study also highlighted the importance of direct contact with patients or their family members: When a family member was reached by the navigator the no-show rate fell to just 3%[66].

Over the last three decades there has been tremendous interest in developing tools for delivering oncologic care remotely to improve equitable access to care. Published studies mostly describe implementation, and outcome data are rare. As an example, the oncology group at the University of Kansas has published both descriptions and cost analyses of their tele-oncology practice since the mid-1990s, though these reports have not accompanied by outcome data[67,68]. In Queensland, Australia a rural hospital partnered with a tertiary care center over 500 miles away. This partnership allowed for chemotherapy administration for solid tumor malignancies via tele-visits. While treatments were first administered in 2007, retrospective results were not published until 2015. These data did demonstrate similar outcomes for rural patients (n = 89) in comparison to a matched group receiving care locally at the tertiary care center (n = 117), though given the lag time between implementation and data publication it would be difficult for other institutions looking at this model to know if it is safe and efficacious until many years after the program started[69]. Another descriptive example of a novel technique is at a single remote California cancer clinic. The clinic partnered with an academic medical center 100 miles away to establish a virtual tumor board to ensure evidence-based care for complex cancer cases[70]. With the increase in precision medicine and genetic testing, tele-genetics has also arisen as a very important aspect of cancer care delivery. Many institutions, such as the VA, have incorporated telephone-based genetic counseling to improve low-cost access to these services; though again outcome data is limited[71,72].

Technology has been trialed to improve care access among patients living in LMICs, though both patient-facing interventions and outcome data are sparse. More often, technology is used to partner with institutions in more wealthy countries. For example, in Jordan, a partnership with a Canadian institution allowed access to a multidisciplinary care conference for pediatric neuro-oncology care with the use of videoconference to present data. In the Solomon Islands, a pathology group used electronic communication (primarily email) to discuss cases with a group in Switzerland[73,74]. Again, these manuscripts describe the process of implementation rather than report on patient outcomes with the interventions. Studying implementation with care is needed as neither the risks and benefits, nor the resource usage, of these techniques is known.

Palliation and Survivorship

Four United States based RCTs have evaluated technology-based interventions to deliver palliative and supportive care among minority and low-income patients with cancer. A multisite study in community oncology practices in Indiana randomized patients with any cancer and a diagnosis of depression or cancer related pain (n = 405). The intervention included telephone visits along with online symptom monitoring by a nurse trained to provide relevant treatment options; this was then compared to an arm receiving usual care. Pain and depression scores improved for the randomized group as compared to the control (P < 0.01)[75]. Among predominantly Black patients with advanced prostate cancer (n = 76) in a single clinic in Chicago, a cognitive-behavioral stress management tool to reduce symptom burden provided to patients on a tablet computer led to a reduction in depressive symptoms (P = 0.06)[76]. In a population of rural veterans in Vermont with advanced cancer (n = 322), a palliative care trained nurse practitioner delivered both education and palliation to patients through monthly telephone calls. For the patients randomized to the intervention group, quality of life and mood improved (P = 0.02) but there were no differences in symptom intensity (P = 0.06)[77]. Lastly, the effects of telephone and internet-based patient navigation on quality of life in Hispanic survivors (n = 288) was examined. Patients with prostate, breast, or colorectal cancer at two academic medical centers (one in Chicago, IL and the other in San Antonio, TX, United States) were randomized to the control of “standard” patient navigation services, including up to six phone calls with a navigator and print materials from cancer societies, vs a specific navigator program delivered solely via the internet and telephone (the LIVESTRONG cancer navigation service) that included three months of navigation services via one-on-one bilingual support over the telephone or internet that helped provide support for emotional coping, education on treatment options, arranging for appointments, and connecting patients to community resources such as social work, psychosocial services, child care, and financial services. At fifteen months, female patients with colorectal cancer had improvement in the primary outcome, the score of a health-related quality of life scale (P < 0.05). However, there was no difference between the two arms for male colorectal cancer patients, breast cancer patients, or prostate cancer patients[78].

Outside of the United States, there have been only a small number of studies focused on marginalized populations in high income countries. In a multi-site study from Australia that was focused on newly diagnosed rural patients undergoing curative intent treatment (n = 191), patients were randomized to receive a six module online self-guided psychotherapeutic intervention. The goal was to reduce stress and improve quality of life. At six months there was no difference in distress level (P = 0.22) or quality of life (P = 0.62)[79]. While these five studies report on randomized data, there are a number of small scale feasibility studies, predominately from the United States, that have examined various technologies, usually in rural populations[80-87].

To our knowledge, no telehealth palliative care trials involving patients in LMICs have been reported. In a 2013 report, seventy-five nations (32% of countries) had no known hospice or palliative care presence[88]. Furthermore, the poorest half of the world has access to less than 1% of manufactured opioids[89]. The lack of studies in these nations reflects limited resources and palliative care infrastructure. These unmet needs represent opportunities to improve education, implementation, and policy. Given the limited resources, employing tools such as navigation and telehealth may well be invaluable to increase the penetration of palliative care[90].

Summary and Future Directions

Technology interventions have been quickly incorporated into aspects of cancer care practice, often due to convenience and cost, rather than robust evidence demonstrating their efficacy in improving outcomes. The tested interventions to date have not consistently been shown to improve outcomes in screening, follow-up, treatment adherence, or palliation. There are some interventions with robust effect size, though the reproducibility remains unknown. Technology represents a bridge to the masses and is likely to be a key tool in expanding access to care in all countries regardless of income level. As technology interventions can be deployed on existing infrastructure (for example, cell phones) the cost could be considerably less in comparison to “traditional” care and even the use of in-person CHWs. Further investigation and investment into studying the impact of technology interventions is needed.

CONCLUSION

In this review we examine two themes of health service interventions for cancer care: Patient navigation and telehealth. We describe studies designed to improve disparities, with an emphasis on randomized controlled trials and data generated from LMICs. Available studies in both patient navigation and telehealth have been shown to reduce disparities across the cancer care continuum. Patient navigation has the most robust data, primarily in its role in screening and reducing treatment abandonment. Telehealth remains an active area of exploration to improve access to treatment and palliation for patients living in rural settings, although data on the efficacy of these interventions is limited. Continued investigation, iteration, and dissemination of these interventions, and scalability where feasible, can help to identify and reduce barriers to equitable cancer care receipt globally.

Footnotes

Manuscript source: Invited manuscript

Specialty type: Oncology

Country/Territory of origin: United States

Peer-review report’s scientific quality classification

Grade A (Excellent): A

Grade B (Very good): B

Grade C (Good): 0

Grade D (Fair): 0

Grade E (Poor): 0

P-Reviewer: Eseadi C, Kinami S S-Editor: Liu M L-Editor: A P-Editor: Wang LL

References
1.  Centers for Disease Control and Prevention. Strategies for Reducing Health Disparities 2016. [Accessed 2020 January 31].  Available from: https://www.cdc.gov/minorityhealth/strategies2016/index.html.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Prager GW, Braga S, Bystricky B, Qvortrup C, Criscitiello C, Esin E, Sonke GS, Martínez GA, Frenel JS, Karamouzis M, Strijbos M, Yazici O, Bossi P, Banerjee S, Troiani T, Eniu A, Ciardiello F, Tabernero J, Zielinski CC, Casali PG, Cardoso F, Douillard JY, Jezdic S, McGregor K, Bricalli G, Vyas M, Ilbawi A. Global cancer control: responding to the growing burden, rising costs and inequalities in access. ESMO Open. 2018;3:e000285.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 154]  [Cited by in F6Publishing: 142]  [Article Influence: 23.7]  [Reference Citation Analysis (0)]
3.  Office of Disease Prevention and Health Promotion. Disparities. In: Healthy People 2020. [Accessed 2020 February 3].  Available from: https://www.healthypeople.gov/2020/about/foundation-health-measures/Disparities.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  National Cancer Institute. Cancer Health Disparities Research. [Accessed 2020 January 31].  Available from: https://www.cancer.gov/research/areas/disparities.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  United Nations Development Programme. Human Development Index (HDI). [Accessed 2020 January 5].  Available from: http://hdr.undp.org/en/content/human-development-index-hdi.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Cunningham J, Rumbold AR, Zhang X, Condon JR. Incidence, aetiology, and outcomes of cancer in Indigenous peoples in Australia. Lancet Oncol. 2008;9:585-595.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 126]  [Cited by in F6Publishing: 133]  [Article Influence: 8.3]  [Reference Citation Analysis (0)]
7.  Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med. 2008;5:e132.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 351]  [Cited by in F6Publishing: 359]  [Article Influence: 22.4]  [Reference Citation Analysis (0)]
8.  Barzi A, Yang D, Mostofizadeh S, Lenz HJ. Trends in colorectal cancer mortality in hispanics: a SEER analysis. Oncotarget. 2017;8:108771-108777.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 12]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
9.  Anderson KO, Mendoza TR, Payne R, Valero V, Palos GR, Nazario A, Richman SP, Hurley J, Gning I, Lynch GR, Kalish D, Cleeland CS. Pain education for underserved minority cancer patients: a randomized controlled trial. J Clin Oncol. 2004;22:4918-4925.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 76]  [Cited by in F6Publishing: 72]  [Article Influence: 3.8]  [Reference Citation Analysis (0)]
10.  Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291:2720-2726.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1452]  [Cited by in F6Publishing: 1568]  [Article Influence: 78.4]  [Reference Citation Analysis (1)]
11.  Gonzalez BD. Promise of Mobile Health Technology to Reduce Disparities in Patients With Cancer and Survivors. JCO Clin Cancer Inform. 2018;2:1-9.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 20]  [Cited by in F6Publishing: 22]  [Article Influence: 4.4]  [Reference Citation Analysis (0)]
12.  Davoudi Monfared E, Mohseny M, Amanpour F, Mosavi Jarrahi A, Moradi Joo M, Heidarnia MA. Relationship of Social Determinants of Health with the Three-year Survival Rate of Breast Cancer. Asian Pac J Cancer Prev. 2017;18:1121-1126.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 8]  [Reference Citation Analysis (0)]
13.  Merletti F, Galassi C, Spadea T. The socioeconomic determinants of cancer. Environ Health. 2011;10 Suppl 1:S7.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 76]  [Cited by in F6Publishing: 59]  [Article Influence: 4.5]  [Reference Citation Analysis (0)]
14.  World Health Organization. Cancer. [Accessed 2020 February 3].  Available from: https://www.who.int/news-room/fact-sheets/detail/cancer.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  National Cancer Institute. What are cancer disparities? [Accessed 2020 February 3]. In: National Institutes of Health.  Available from: https://www.cancer.gov/about-cancer/understanding/disparities.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Gelband H, Jha P, Sankaranarayanan R, Horton S. Cancer: Disease Control Priorities, Third Edition (Volume 3).  Washington, DC: The World Bank, 2015.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  The Word Bank. Low and middle income. [Accessed 2020 April 9].  Available from: https://data.worldbank.org/income-level/Low-and-middle-income.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  National Heart, Lung and Blood Institute. Role of Community Health Workers. [Accessed 2020 February 15].  Available from: https://www.nhlbi.nih.gov/health/educational/healthdisp/role-of-community-health-workers.htm.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  National Cancer Institute. Definition of patient navigator. [Accessed 2020 January 5].  Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/patient-navigator.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Hesketh T, Wei XZ. Health in China. From Mao to market reform. BMJ. 1997;314:1543-1545.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 63]  [Cited by in F6Publishing: 50]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
21.  Wen C. Barefoot doctors in China. Nurs Dig. 1975;3:26-28.  [PubMed]  [DOI]  [Cited in This Article: ]
22.  Freeman HP, Rodriguez RL. History and principles of patient navigation. Cancer. 2011;117:3539-3542.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 171]  [Cited by in F6Publishing: 267]  [Article Influence: 20.5]  [Reference Citation Analysis (0)]
23.  Freeman HP, Wasfie TJ. Cancer of the breast in poor black women. Cancer. 1989;63:2562-2569.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
24.  Oluwole SF, Ali AO, Adu A, Blane BP, Barlow B, Oropeza R, Freeman HP. Impact of a cancer screening program on breast cancer stage at diagnosis in a medically underserved urban community. J Am Coll Surg. 2003;196:180-188.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 105]  [Cited by in F6Publishing: 113]  [Article Influence: 5.4]  [Reference Citation Analysis (0)]
25.  Grubbs SS, Polite BN, Carney J, Bowser W, Rogers J, Katurakes N, Hess P, Paskett ED. Eliminating racial disparities in colorectal cancer in the real world: it took a village. J Clin Oncol. 2013;31:1928-1930.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 105]  [Cited by in F6Publishing: 136]  [Article Influence: 12.4]  [Reference Citation Analysis (0)]
26.  National Cancer Institute. NCI Center to Reduce Cancer Health Disparities (CRCHD). [Accessed 2019 November 15].  Available from: https://www.cancer.gov/about-nci/organization/crchd/disparities-research/pnrp.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Percac-Lima S, Grant RW, Green AR, Ashburner JM, Gamba G, Oo S, Richter JM, Atlas SJ. A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial. J Gen Intern Med. 2009;24:211-217.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 213]  [Cited by in F6Publishing: 247]  [Article Influence: 16.5]  [Reference Citation Analysis (0)]
28.  Marshall JK, Mbah OM, Ford JG, Phelan-Emrick D, Ahmed S, Bone L, Wenzel J, Shapiro GR, Howerton M, Johnson L, Brown Q, Ewing A, Pollack CE. Effect of Patient Navigation on Breast Cancer Screening Among African American Medicare Beneficiaries: A Randomized Controlled Trial. J Gen Intern Med. 2016;31:68-76.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 44]  [Cited by in F6Publishing: 54]  [Article Influence: 6.8]  [Reference Citation Analysis (0)]
29.  Freund KM, Battaglia TA, Calhoun E, Darnell JS, Dudley DJ, Fiscella K, Hare ML, LaVerda N, Lee JH, Levine P, Murray DM, Patierno SR, Raich PC, Roetzheim RG, Simon M, Snyder FR, Warren-Mears V, Whitley EM, Winters P, Young GS, Paskett ED; Writing Group of the Patient Navigation Research Program. Impact of patient navigation on timely cancer care: the Patient Navigation Research Program. J Natl Cancer Inst. 2014;106:dju115.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 147]  [Cited by in F6Publishing: 181]  [Article Influence: 18.1]  [Reference Citation Analysis (0)]
30.  Dalton M, Holzman E, Erwin E, Michelen S, Rositch AF, Kumar S, Vanderpuye V, Yeates K, Liebermann EJ, Ginsburg O. Patient navigation services for cancer care in low-and middle-income countries: A scoping review. PLoS One. 2019;14:e0223537.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 32]  [Cited by in F6Publishing: 49]  [Article Influence: 9.8]  [Reference Citation Analysis (0)]
31.  Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med. 2010;363:1203-1210.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 363]  [Cited by in F6Publishing: 328]  [Article Influence: 23.4]  [Reference Citation Analysis (0)]
32.  Sankaranarayanan R, Ramadas K, Thara S, Muwonge R, Prabhakar J, Augustine P, Venugopal M, Anju G, Mathew BS. Clinical breast examination: preliminary results from a cluster randomized controlled trial in India. J Natl Cancer Inst. 2011;103:1476-1480.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 144]  [Cited by in F6Publishing: 143]  [Article Influence: 11.0]  [Reference Citation Analysis (0)]
33.  Mittra I, Mishra GA, Singh S, Aranke S, Notani P, Badwe R, Miller AB, Daniel EE, Gupta S, Uplap P, Thakur MH, Ramani S, Kerkar R, Ganesh B, Shastri SS. A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. Int J Cancer. 2010;126:976-984.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 20]  [Cited by in F6Publishing: 62]  [Article Influence: 4.4]  [Reference Citation Analysis (0)]
34.  Pisani P, Parkin DM, Ngelangel C, Esteban D, Gibson L, Munson M, Reyes MG, Laudico A. Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer. 2006;118:149-154.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 126]  [Cited by in F6Publishing: 120]  [Article Influence: 6.3]  [Reference Citation Analysis (0)]
35.  Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Chen FL, Porter P, Hu YW, Zhao GL, Pan LD, Li W, Wu C, Coriaty Z, Evans I, Lin MG, Stalsberg H, Self SG. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst. 2002;94:1445-1457.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 431]  [Cited by in F6Publishing: 466]  [Article Influence: 21.2]  [Reference Citation Analysis (0)]
36.  Ginsburg OM, Chowdhury M, Wu W, Chowdhury MT, Pal BC, Hasan R, Khan ZH, Dutta D, Saeem AA, Al-Mansur R, Mahmud S, Woods JH, Story HH, Salim R. An mHealth model to increase clinic attendance for breast symptoms in rural Bangladesh: can bridging the digital divide help close the cancer divide? Oncologist. 2014;19:177-185.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 47]  [Cited by in F6Publishing: 45]  [Article Influence: 4.5]  [Reference Citation Analysis (0)]
37.  Patient Navigator Training Collaborative. Navigate to new knowledge and skills. [Accessed 2020 February 15].  Available from: https://patientnavigatortraining.org/.  [PubMed]  [DOI]  [Cited in This Article: ]
38.  Riogi B, Wasike R, Saidi H. Effect of a breast navigation programme in a teaching hospital in Africa. South African J Oncol. 2017;6.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 4]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
39.  Vasconcelos CTM, Pinheiro AKB, Pinheiro AIO, Lima TM, Barbosa D de FF. Comparison among the efficacy of interventions for the return rate to receive the pap test report: randomized controlled clinical trial. Rev Lat Am Enfermagem. 2017;25:e2857.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in F6Publishing: 3]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
40.  Ell K, Vourlekis B, Xie B, Nedjat-Haiem FR, Lee PJ, Muderspach L, Russell C, Palinkas LA. Cancer treatment adherence among low-income women with breast or gynecologic cancer: a randomized controlled trial of patient navigation. Cancer. 2009;115:4606-4615.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 102]  [Cited by in F6Publishing: 100]  [Article Influence: 6.7]  [Reference Citation Analysis (0)]
41.  Fouad MN, Acemgil A, Bae S, Forero A, Lisovicz N, Martin MY, Oates GR, Partridge EE, Vickers SM. Patient Navigation As a Model to Increase Participation of African Americans in Cancer Clinical Trials. J Oncol Pract. 2016;12:556-563.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 69]  [Cited by in F6Publishing: 72]  [Article Influence: 9.0]  [Reference Citation Analysis (0)]
42.  Cykert S, Eng E, Walker P, Manning MA, Robertson LB, Arya R, Jones NS, Heron DE. A system-based intervention to reduce Black-White disparities in the treatment of early stage lung cancer: A pragmatic trial at five cancer centers. Cancer Med. 2019;8:1095-1102.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 49]  [Cited by in F6Publishing: 44]  [Article Influence: 8.8]  [Reference Citation Analysis (0)]
43.  Dudley DJ, Drake J, Quinlan J, Holden A, Saegert P, Karnad A, Ramirez A. Beneficial effects of a combined navigator/promotora approach for Hispanic women diagnosed with breast abnormalities. Cancer Epidemiol Biomarkers Prev. 2012;21:1639-1644.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 49]  [Cited by in F6Publishing: 57]  [Article Influence: 4.8]  [Reference Citation Analysis (0)]
44.  Guadagnolo BA, Boylan A, Sargent M, Koop D, Brunette D, Kanekar S, Shortbull V, Molloy K, Petereit DG. Patient navigation for American Indians undergoing cancer treatment: utilization and impact on care delivery in a regional healthcare center. Cancer. 2011;117:2754-2761.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 38]  [Cited by in F6Publishing: 53]  [Article Influence: 3.8]  [Reference Citation Analysis (0)]
45.  Alvarez E, Seppa M, Rivas S, Fuentes L, Valverde P, Antillón-Klussmann F, Castellanos M, Sweet-Cordero EA, Messacar K, Kurap J, Bustamante M, Howard SC, Efron B, Luna-Fineman S. Improvement in treatment abandonment in pediatric patients with cancer in Guatemala. Pediatr Blood Cancer. 2017;64.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 30]  [Article Influence: 4.3]  [Reference Citation Analysis (0)]
46.  Yeoh ZY, Jaganathan M, Rajaram N, Rawat S, Tajudeen NA, Rahim N, Zainal NH, Maniam S, Suvelayutnan U, Yaacob R, Krishnapillai V, Kamal MZM, Teo SH, Wahab MYA. Feasibility of Patient Navigation to Improve Breast Cancer Care in Malaysia. J Glob Oncol. 2018;4:1-13.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 12]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
47.  Turkman YE, Williams CP, Jackson BE, Dionne-Odom JN, Taylor R, Ejem D, Kvale E, Pisu M, Bakitas M, Rocque GB. Disparities in Hospice Utilization for Older Cancer Patients Living in the Deep South. J Pain Symptom Manage. 2019;58:86-91.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 9]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
48.  World Health Organization. Strengthening of palliative care as a component of integrated treatment throughout the life course. J Pain Palliat Care Pharmacother. 2014;28:130-134.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 120]  [Cited by in F6Publishing: 212]  [Article Influence: 21.2]  [Reference Citation Analysis (0)]
49.  Fischer SM, Cervantes L, Fink RM, Kutner JS. Apoyo con Cariño: a pilot randomized controlled trial of a patient navigator intervention to improve palliative care outcomes for Latinos with serious illness. J Pain Symptom Manage. 2015;49:657-665.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 55]  [Cited by in F6Publishing: 54]  [Article Influence: 6.0]  [Reference Citation Analysis (0)]
50.  Patel MI, Sundaram V, Desai M, Periyakoil VS, Kahn JS, Bhattacharya J, Asch SM, Milstein A, Bundorf MK. Effect of a Lay Health Worker Intervention on Goals-of-Care Documentation and on Health Care Use, Costs, and Satisfaction Among Patients With Cancer: A Randomized Clinical Trial. JAMA Oncol. 2018;4:1359-1366.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 57]  [Cited by in F6Publishing: 58]  [Article Influence: 11.6]  [Reference Citation Analysis (0)]
51.  Patel MI, Ramirez D, Agajanian R, Agajanian HH, Bhattacharya J, Coker T. Enhancing community capacity to improve cancer care delivery and the effect on patient-reported outcomes, healthcare utilization and total costs of care. J Clin Oncol. 2019;37 suppl 15:6522-6522.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in F6Publishing: 2]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
52.  Patel MI, Ramirez D, Agajanian R, Bhattacharya J, Milstein A, Bundorf K. The effect of a lay health worker-led symptom assessment intervention for patients on patient-reported outcomes, healthcare use, and total costs. J Clin Oncol. 2018;36 suppl 15:6502-6502.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in F6Publishing: 1]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
53.  Schwebel FJ, Larimer ME. Using text message reminders in health care services: A narrative literature review. Internet Interv. 2018;13:82-104.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 119]  [Cited by in F6Publishing: 111]  [Article Influence: 18.5]  [Reference Citation Analysis (0)]
54.  Børøsund E, Varsi C, Clark MM, Ehlers SL, Andrykowski MA, Sleveland HRS, Bergland A, Nes LS. Pilot testing an app-based stress management intervention for cancer survivors. Transl Behav Med. 2019;ibz062.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 22]  [Cited by in F6Publishing: 22]  [Article Influence: 7.3]  [Reference Citation Analysis (0)]
55.  Allen JD, Mohllajee AP, Shelton RC, Drake BF, Mars DR. A computer-tailored intervention to promote informed decision making for prostate cancer screening among African American men. Am J Mens Health. 2009;3:340-351.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 27]  [Cited by in F6Publishing: 31]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
56.  Pew Research Center. Mobile Divides in Emerging Countries. [Accessed 2020 January 5].  Available from: https://www.pewresearch.org/internet/2019/11/20/mobile-divides-in-emerging-economies/.  [PubMed]  [DOI]  [Cited in This Article: ]
57.  Charib M. Surprising Charts About Smoking, Unemployment And Mobile Phones. In: World Bank Charts For 2016 Show Surprising Trends - And Looming Challenges: Goats and Soda. NPR. [Accessed 2020 January 5].  Available from: https://www.npr.org/sections/goatsandsoda/2017/01/14/509137225/surprising-charts-about-smoking-unemployment-and-mobile-phones.  [PubMed]  [DOI]  [Cited in This Article: ]
58.  ITU. Measuring digital development: Facts and figures 2019. [Accessed 2020 January 5].  Available from: https://www.itu.int/en/ITU-D/Statistics/Pages/facts/default.aspx.  [PubMed]  [DOI]  [Cited in This Article: ]
59.  Sirintrapun SJ, Lopez AM. Telemedicine in Cancer Care. Am Soc Clin Oncol Educ Book. 2018;38:540-545.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 165]  [Cited by in F6Publishing: 206]  [Article Influence: 34.3]  [Reference Citation Analysis (0)]
60.  Kreuter MW, Alcaraz KI, Pfeiffer D, Christopher K. Using dissemination research to identify optimal community settings for tailored breast cancer information kiosks. J Public Health Manag Pract. 2008;14:160-169.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 21]  [Cited by in F6Publishing: 24]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
61.  Santos SL, Tagai EK, Wang MQ, Scheirer MA, Slade JL, Holt CL. Feasibility of a web-based training system for peer community health advisors in cancer early detection among african americans. Am J Public Health. 2014;104:2282-2289.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 24]  [Cited by in F6Publishing: 23]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
62.  Champion VL, Springston JK, Zollinger TW, Saywell RM, Monahan PO, Zhao Q, Russell KM. Comparison of three interventions to increase mammography screening in low income African American women. Cancer Detect Prev. 2006;30:535-544.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 62]  [Cited by in F6Publishing: 71]  [Article Influence: 3.9]  [Reference Citation Analysis (0)]
63.  Russell KM, Champion VL, Monahan PO, Millon-Underwood S, Zhao Q, Spacey N, Rush NL, Paskett ED. Randomized trial of a lay health advisor and computer intervention to increase mammography screening in African American women. Cancer Epidemiol Biomarkers Prev. 2010;19:201-210.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 48]  [Cited by in F6Publishing: 53]  [Article Influence: 3.8]  [Reference Citation Analysis (0)]
64.  Greiner KA, Daley CM, Epp A, James A, Yeh HW, Geana M, Born W, Engelman KK, Shellhorn J, Hester CM, LeMaster J, Buckles DC, Ellerbeck EF. Implementation intentions and colorectal screening: a randomized trial in safety-net clinics. Am J Prev Med. 2014;47:703-714.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 28]  [Cited by in F6Publishing: 30]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
65.  Helzlsouer KJ, Appling SE, Gallicchio L, Henninger D, MacDonald R, Manocheh S, Scarvalone S, Varanasi AP. A Pilot Study of a Virtual Navigation Program to Improve Treatment Adherence Among Low-Income Breast Cancer Patients. J Oncol Navig Surviv. 2016;7:7.  [PubMed]  [DOI]  [Cited in This Article: ]
66.  Percac-Lima S, Cronin PR, Ryan DP, Chabner BA, Daly EA, Kimball AB. Patient navigation based on predictive modeling decreases no-show rates in cancer care. Cancer. 2015;121:1662-1670.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 27]  [Cited by in F6Publishing: 29]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
67.  Doolittle GC, Harmon A, Williams A, Allen A, Boysen CD, Wittman C, Mair F, Carlson E. A cost analysis of a tele-oncology practice. J Telemed Telecare. 1997;3 Suppl 1:20-22.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 28]  [Cited by in F6Publishing: 29]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
68.  Doolittle GC, Spaulding AO. Providing Access to Oncology Care for Rural Patients via Telemedicine. J Oncol Pract. 2006;2:228-230.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 65]  [Cited by in F6Publishing: 60]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
69.  Chan BA, Larkins SL, Evans R, Watt K, Sabesan S. Do teleoncology models of care enable safe delivery of chemotherapy in rural towns? Med J Aust. 2015;203:406-6.e6.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 28]  [Cited by in F6Publishing: 28]  [Article Influence: 3.1]  [Reference Citation Analysis (0)]
70.  Heifetz LJ, Christensen SD, Devere-White RW, Meyers FJ. A model for rural oncology. J Oncol Pract. 2011;7:168-171.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 12]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
71.  McDonald E, Lamb A, Grillo B, Lucas L, Miesfeldt S. Acceptability of telemedicine and other cancer genetic counseling models of service delivery in geographically remote settings. J Genet Couns. 2014;23:221-228.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 34]  [Cited by in F6Publishing: 31]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
72.  Genomic Medicine and Genetic Counseling in the Department of Veterans Affairs and Department of Defense (FULL). AVAHO. [Accessed 2020 January 5].  Available from: https://www.mdedge.com/fedprac/avaho/article/206097/oncology/genomic-medicine-and-genetic-counseling-department-veterans.  [PubMed]  [DOI]  [Cited in This Article: ]
73.  Qaddoumi I, Mansour A, Musharbash A, Drake J, Swaidan M, Tihan T, Bouffet E. Impact of telemedicine on pediatric neuro-oncology in a developing country: the Jordanian-Canadian experience. Pediatr Blood Cancer. 2007;48:39-43.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 66]  [Cited by in F6Publishing: 63]  [Article Influence: 3.7]  [Reference Citation Analysis (0)]
74.  Brauchli K, Jagilly R, Oberli H, Kunze KD, Phillips G, Hurwitz N, Oberholzer M. Telepathology on the Solomon Islands--two years' experience with a hybrid Web- and email-based telepathology system. J Telemed Telecare. 2004;10 Suppl 1:14-17.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 30]  [Cited by in F6Publishing: 31]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
75.  Kroenke K, Theobald D, Wu J, Norton K, Morrison G, Carpenter J, Tu W. Effect of telecare management on pain and depression in patients with cancer: a randomized trial. JAMA. 2010;304:163-171.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 259]  [Cited by in F6Publishing: 235]  [Article Influence: 16.8]  [Reference Citation Analysis (0)]
76.  Yanez B, McGinty HL, Mohr DC, Begale MJ, Dahn JR, Flury SC, Perry KT, Penedo FJ. Feasibility, acceptability, and preliminary efficacy of a technology-assisted psychosocial intervention for racially diverse men with advanced prostate cancer. Cancer. 2015;121:4407-4415.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 57]  [Cited by in F6Publishing: 62]  [Article Influence: 6.9]  [Reference Citation Analysis (0)]
77.  Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC, Seville J, Hull JG, Li Z, Tosteson TD, Byock IR, Ahles TA. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA. 2009;302:741-749.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1256]  [Cited by in F6Publishing: 1218]  [Article Influence: 81.2]  [Reference Citation Analysis (0)]
78.  Ramirez AG, Choi BY, Munoz E, Perez A, Gallion KJ, Moreno PI, Penedo FJ. Assessing the effect of patient navigator assistance for psychosocial support services on health-related quality of life in a randomized clinical trial in Latino breast, prostate, and colorectal cancer survivors. Cancer. 2020;126:1112-1123.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 9]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
79.  Beatty L, Kemp E, Coll JR, Turner J, Butow P, Milne D, Yates P, Lambert S, Wootten A, Yip D, Koczwara B. Finding My Way: results of a multicentre RCT evaluating a web-based self-guided psychosocial intervention for newly diagnosed cancer survivors. Support Care Cancer. 2019;27:2533-2544.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 13]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
80.  Passik SD, Kirsh KL, Leibee S, Kaplan LS, Love C, Napier E, Burton D, Sprang R. A feasibility study of dignity psychotherapy delivered via telemedicine. Palliat Support Care. 2004;2:149-155.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 27]  [Cited by in F6Publishing: 28]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
81.  Rocque GB, Halilova KI, Varley AL, Williams CP, Taylor RA, Masom DG, Wright WJ, Partridge EE, Kvale EA. Feasibility of a Telehealth Educational Program on Self-Management of Pain and Fatigue in Adult Cancer Patients. J Pain Symptom Manage. 2017;53:1071-1078.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 12]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
82.  Doorenbos AZ, Eaton LH, Haozous E, Towle C, Revels L, Buchwald D. Satisfaction with telehealth for cancer support groups in rural American Indian and Alaska Native communities. Clin J Oncol Nurs. 2010;14:765-770.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 40]  [Cited by in F6Publishing: 37]  [Article Influence: 2.6]  [Reference Citation Analysis (0)]
83.  Pruthi S, Stange KJ, Malagrino GD, Chawla KS, LaRusso NF, Kaur JS. Successful implementation of a telemedicine-based counseling program for high-risk patients with breast cancer. Mayo Clin Proc. 2013;88:68-73.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 30]  [Cited by in F6Publishing: 24]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
84.  Melton L, Brewer B, Kolva E, Joshi T, Bunch M. Increasing access to care for young adults with cancer: Results of a quality-improvement project using a novel telemedicine approach to supportive group psychotherapy. Palliat Support Care. 2017;15:176-180.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 32]  [Cited by in F6Publishing: 31]  [Article Influence: 3.9]  [Reference Citation Analysis (0)]
85.  Guzman D, Ann-Yi S, Bruera E, Wu J, Williams JL, Najera J, Raznahan M, Carmack CL. Enhancing palliative care patient access to psychological counseling through outreach telehealth services. Psychooncology. 2020;29:132-138.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 21]  [Article Influence: 4.2]  [Reference Citation Analysis (0)]
86.  Johnson-Turbes A, Schlueter D, Moore AR, Buchanan ND, Fairley TL. Evaluation of a Web-Based Program for African American Young Breast Cancer Survivors. Am J Prev Med. 2015;49:S543-S549.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 13]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
87.  Patel MI, Ramirez D, Agajanian R, Agajanian H, Coker T. Association of a Lay Health Worker Intervention With Symptom Burden, Survival, Health Care Use, and Total Costs Among Medicare Enrollees With Cancer. JAMA Netw Open. 2020;3:e201023.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 20]  [Article Influence: 5.0]  [Reference Citation Analysis (0)]
88.  Lynch T, Connor S, Clark D. Mapping levels of palliative care development: a global update. J Pain Symptom Manage. 2013;45:1094-1106.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 320]  [Cited by in F6Publishing: 330]  [Article Influence: 30.0]  [Reference Citation Analysis (0)]
89.  Knaul FM, Farmer PE, Krakauer EL, De Lima L, Bhadelia A, Jiang Kwete X, Arreola-Ornelas H, Gómez-Dantés O, Rodriguez NM, Alleyne GAO, Connor SR, Hunter DJ, Lohman D, Radbruch L, Del Rocío Sáenz Madrigal M, Atun R, Foley KM, Frenk J, Jamison DT, Rajagopal MR; Lancet Commission on Palliative Care and Pain Relief Study Group. Alleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: the Lancet Commission report. Lancet. 2018;391:1391-1454.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 545]  [Cited by in F6Publishing: 599]  [Article Influence: 99.8]  [Reference Citation Analysis (0)]
90.  World Palliative Care Alliance. World Health Organization. Global Atlas of Palliative Care at the End of Life. 2014.  Available from: http://www.who.int/cancer/publications/palliative-care-atlas/en/.  [PubMed]  [DOI]  [Cited in This Article: ]
91.  Jandorf L, Gutierrez Y, Lopez J, Christie J, Itzkowitz SH. Use of a patient navigator to increase colorectal cancer screening in an urban neighborhood health clinic. J Urban Health. 2005;82:216-224.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 174]  [Cited by in F6Publishing: 187]  [Article Influence: 9.8]  [Reference Citation Analysis (0)]
92.  Tu SP, Taylor V, Yasui Y, Chun A, Yip MP, Acorda E, Li L, Bastani R. Promoting culturally appropriate colorectal cancer screening through a health educator: a randomized controlled trial. Cancer. 2006;107:959-966.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 85]  [Cited by in F6Publishing: 100]  [Article Influence: 5.6]  [Reference Citation Analysis (0)]
93.  Christie J, Itzkowitz S, Lihau-Nkanza I, Castillo A, Redd W, Jandorf L. A randomized controlled trial using patient navigation to increase colonoscopy screening among low-income minorities. J Natl Med Assoc. 2008;100:278-284.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 125]  [Cited by in F6Publishing: 143]  [Article Influence: 8.9]  [Reference Citation Analysis (0)]
94.  Ma GX, Shive S, Tan Y, Gao W, Rhee J, Park M, Kim J, Toubbeh JI. Community-based colorectal cancer intervention in underserved Korean Americans. Cancer Epidemiol. 2009;33:381-386.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 61]  [Cited by in F6Publishing: 72]  [Article Influence: 4.8]  [Reference Citation Analysis (0)]
95.  Phillips CE, Rothstein JD, Beaver K, Sherman BJ, Freund KM, Battaglia TA. Patient navigation to increase mammography screening among inner city women. J Gen Intern Med. 2011;26:123-129.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 95]  [Cited by in F6Publishing: 87]  [Article Influence: 6.7]  [Reference Citation Analysis (0)]
96.  Lasser KE, Murillo J, Lisboa S, Casimir AN, Valley-Shah L, Emmons KM, Fletcher RH, Ayanian JZ. Colorectal cancer screening among ethnically diverse, low-income patients: a randomized controlled trial. Arch Intern Med. 2011;171:906-912.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 135]  [Cited by in F6Publishing: 151]  [Article Influence: 11.6]  [Reference Citation Analysis (0)]
97.  Myers RE, Sifri R, Daskalakis C, DiCarlo M, Geethakumari PR, Cocroft J, Minnick C, Brisbon N, Vernon SW. Increasing colon cancer screening in primary care among African Americans. J Natl Cancer Inst. 2014;106:dju344.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 39]  [Cited by in F6Publishing: 44]  [Article Influence: 4.4]  [Reference Citation Analysis (0)]
98.  Braschi CD, Sly JR, Singh S, Villagra C, Jandorf L. Increasing colonoscopy screening for Latino Americans through a patient navigation model: a randomized clinical trial. J Immigr Minor Health. 2014;16:934-940.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 40]  [Cited by in F6Publishing: 46]  [Article Influence: 5.1]  [Reference Citation Analysis (0)]
99.  Enard KR, Nevarez L, Hernandez M, Hovick SR, Moguel MR, Hajek RA, Blinka CE, Jones LA, Torres-Vigil I. Patient navigation to increase colorectal cancer screening among Latino Medicare enrollees: a randomized controlled trial. Cancer Causes Control. 2015;26:1351-1359.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 36]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
100.  Braun KL, Thomas WL, Domingo JL, Allison AL, Ponce A, Haunani Kamakana P, Brazzel SS, Emmett Aluli N, Tsark JU. Reducing cancer screening disparities in medicare beneficiaries through cancer patient navigation. J Am Geriatr Soc. 2015;63:365-370.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 47]  [Cited by in F6Publishing: 43]  [Article Influence: 4.8]  [Reference Citation Analysis (0)]
101.  Percac-Lima S, Ashburner JM, Zai AH, Chang Y, Oo SA, Guimaraes E, Atlas SJ. Patient Navigation for Comprehensive Cancer Screening in High-Risk Patients Using a Population-Based Health Information Technology System: A Randomized Clinical Trial. JAMA Intern Med. 2016;176:930-937.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 51]  [Cited by in F6Publishing: 59]  [Article Influence: 7.4]  [Reference Citation Analysis (0)]
102.  DeGroff A, Schroy PC, Morrissey KG, Slotman B, Rohan EA, Bethel J, Murillo J, Ren W, Niwa S, Leadbetter S, Joseph D. Patient Navigation for Colonoscopy Completion: Results of an RCT. Am J Prev Med. 2017;53:363-372.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 43]  [Cited by in F6Publishing: 54]  [Article Influence: 7.7]  [Reference Citation Analysis (0)]
103.  Thompson B, Carosso EA, Jhingan E, Wang L, Holte SE, Byrd TL, Benavides MC, Lopez C, Martinez-Gutierrez J, Ibarra G, Gonzalez VJ, Gonzalez NE, Duggan CR. Results of a randomized controlled trial to increase cervical cancer screening among rural Latinas. Cancer. 2017;123:666-674.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 47]  [Article Influence: 5.9]  [Reference Citation Analysis (0)]
104.  Ma GX, Lee M, Beeber M, Das R, Feng Z, Wang MQ, Tan Y, Zhu L, Navder K, Shireman TI, Siu P, Rhee J, Nguyen MT. Community-Clinical Linkage Intervention to Improve Colorectal Cancer Screening Among Underserved Korean Americans. Cancer Health Disparities. 2019;3:e1-e15.  [PubMed]  [DOI]  [Cited in This Article: ]
105.  Ell K, Vourlekis B, Lee PJ, Xie B. Patient navigation and case management following an abnormal mammogram: a randomized clinical trial. Prev Med. 2007;44:26-33.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 166]  [Cited by in F6Publishing: 173]  [Article Influence: 10.2]  [Reference Citation Analysis (0)]
106.  Ferrante JM, Chen PH, Kim S. The effect of patient navigation on time to diagnosis, anxiety, and satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. J Urban Health. 2008;85:114-124.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 178]  [Cited by in F6Publishing: 159]  [Article Influence: 9.9]  [Reference Citation Analysis (0)]
107.  Raich PC, Whitley EM, Thorland W, Valverde P, Fairclough D; Denver Patient Navigation Research Program. Patient navigation improves cancer diagnostic resolution: an individually randomized clinical trial in an underserved population. Cancer Epidemiol Biomarkers Prev. 2012;21:1629-1638.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 107]  [Cited by in F6Publishing: 116]  [Article Influence: 9.7]  [Reference Citation Analysis (0)]
108.  Lee JH, Fulp W, Wells KJ, Meade CD, Calcano E, Roetzheim R. Patient navigation and time to diagnostic resolution: results for a cluster randomized trial evaluating the efficacy of patient navigation among patients with breast cancer screening abnormalities, Tampa, FL. PLoS One. 2013;8:e74542.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 20]  [Cited by in F6Publishing: 22]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
109.  Ma GX, Yin L, Gao W, Tan Y, Liu R, Fang C, Ma XS. Workplace-based breast cancer screening intervention in china. Cancer Epidemiol Biomarkers Prev. 2012;21:358-367.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 14]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
110.  Shastri SS, Mittra I, Mishra GA, Gupta S, Dikshit R, Singh S, Badwe RA. Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India. J Natl Cancer Inst. 2014;106:dju009.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 140]  [Cited by in F6Publishing: 154]  [Article Influence: 15.4]  [Reference Citation Analysis (0)]
111.  Abiodun OA, Olu-Abiodun OO, Sotunsa JO, Oluwole FA. Impact of health education intervention on knowledge and perception of cervical cancer and cervical screening uptake among adult women in rural communities in Nigeria. BMC Public Health. 2014;14:814.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 94]  [Cited by in F6Publishing: 93]  [Article Influence: 9.3]  [Reference Citation Analysis (0)]
112.  Rosser JI, Njoroge B, Huchko MJ. Changing knowledge, attitudes, and behaviors regarding cervical cancer screening: The effects of an educational intervention in rural Kenya. Patient Educ Couns. 2015;98:884-889.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 52]  [Cited by in F6Publishing: 50]  [Article Influence: 5.6]  [Reference Citation Analysis (0)]
113.  Lima TM, Nicolau AI, Carvalho FH, Vasconcelos CT, Aquino PS, Pinheiro AK. Telephone interventions for adherence to colpocytological examination. Rev Lat Am Enfermagem. 2017;25:e2844.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 9]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
114.  Mishra GS, Bhatt SH. Novel Program of Using Village Health Workers in Early Detection and Awareness of Head and Neck Cancers: Audit of a Community Screening Program. Indian J Otolaryngol Head Neck Surg. 2017;69:488-493.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in F6Publishing: 8]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
115.  Chavarri-Guerra Y, Soto-Perez-de-Celis E, Ramos-López W, San Miguel de Majors SL, Sanchez-Gonzalez J, Ahumada-Tamayo S, Viramontes-Aguilar L, Sanchez-Gutierrez O, Davila-Davila B, Rojo-Castillo P, Perez-Montessoro V, Bukowski A, Goss PE. Patient Navigation to Enhance Access to Care for Underserved Patients with a Suspicion or Diagnosis of Cancer. Oncologist. 2019;24:1195-1200.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 5]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
116.  Mireles-Aguilar T, Tamez-Salazar J, Muñoz-Lozano JF, Lopez-Martinez EA, Romero C, Platas A, Villarreal-Garza C. Alerta Rosa: Novel Alert and Navigation Breast Cancer Program in Nuevo Leon, Mexico, for Reducing Health System Interval Delays. Oncologist. 2018;23:1461-1466.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in F6Publishing: 5]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
117.  Li X, Zhang Y, Gao H, Sun X, Lv W, Xu G. The Value of Extended Nursing Services on Patients with Bladder Cancer after Endoscopic Bladder Resection. Iran J Public Health. 2016;45:48-53.  [PubMed]  [DOI]  [Cited in This Article: ]
118.  Sajjad S, Ali A, Gul RB, Mateen A, Rozi S. The effect of individualized patient education, along with emotional support, on the quality of life of breast cancer patients - A pilot study. Eur J Oncol Nurs. 2016;21:75-82.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 29]  [Article Influence: 3.6]  [Reference Citation Analysis (0)]
119.  Kochaki Nejad Z, Mohajjel Aghdam A, Hassankhani H, Sanaat Z. The Effects of a Patient-Caregiver Education and Follow-Up Program on the Breast Cancer Caregiver Strain Index. Iran Red Crescent Med J. 2016;18:e21627.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 16]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
120.  Miller DP, Kimberly JR, Case LD, Wofford JL. Using a computer to teach patients about fecal occult blood screening. A randomized trial. J Gen Intern Med. 2005;20:984-988.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 27]  [Cited by in F6Publishing: 28]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
121.  Dignan MB, Burhansstipanov L, Hariton J, Harjo L, Rattler T, Lee R, Mason M. A comparison of two Native American Navigator formats: face-to-face and telephone. Cancer Control. 2005;12 Suppl 2:28-33.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 54]  [Cited by in F6Publishing: 61]  [Article Influence: 3.4]  [Reference Citation Analysis (0)]
122.  Miller DP, Spangler JG, Case LD, Goff DC, Singh S, Pignone MP. Effectiveness of a web-based colorectal cancer screening patient decision aid: a randomized controlled trial in a mixed-literacy population. Am J Prev Med. 2011;40:608-615.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 88]  [Cited by in F6Publishing: 94]  [Article Influence: 7.2]  [Reference Citation Analysis (0)]
123.  Fernández ME, Savas LS, Carmack CC, Chan W, Lairson DR, Byrd TL, Wilson KM, Arvey SR, Krasny S, Vernon SW. A randomized controlled trial of two interventions to increase colorectal cancer screening among Hispanics on the Texas-Mexico border. Cancer Causes Control. 2015;26:1-10.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 14]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
124.  Valdez A, Napoles AM, Stewart SL, Garza A. A Randomized Controlled Trial of a Cervical Cancer Education Intervention for Latinas Delivered Through Interactive, Multimedia Kiosks. J Cancer Educ. 2018;33:222-230.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 22]  [Article Influence: 3.7]  [Reference Citation Analysis (0)]
125.  Anderson KO, Palos GR, Mendoza TR, Cleeland CS, Liao KP, Fisch MJ, Garcia-Gonzalez A, Rieber AG, Nazario LA, Valero V, Hahn KM, Person CL, Payne R. Automated pain intervention for underserved minority women with breast cancer. Cancer. 2015;121:1882-1890.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 21]  [Cited by in F6Publishing: 21]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]